• to reduced the potential risk of critical cardiovascular (coronary heart and blood vessel) problems in Grownups with sort 2 diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched plans for an experimental weight loss tablet in May but remains hoping to get a slice of the marketplace with MariTide, a monthly injection that … Read More